GOTHENBURG, SWEDEN / ACCESS Newswire / April 25, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, April 25, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company ...

New Report Ranks Top Vendors and Reveals Strategic ROI Insights from Healthcare Finance Leaders NEW YORK CITY, NEW YORK / ...

Lund, Sweden, 24 April 2025 . Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced the appointment of Renée ...

Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical modelsAnti-IL1RAP ADC targets IL1RAP, which is overexpressed in many tumors and their tumor ...

Clinical findings show association between nadunolimab and lower incidence and later onset of CIPNPreclinical data show prevention of both chemotherapy- and antibody-drug conjugate- (ADC) ...

The pharmaceutical industry is undergoing a transformative era driven by increasingly stringent global regulatory requirements, significantly impacting operational processes, particularly those ...

Conference/Scientific publicationPentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 25.04.2025 / 15:39 CET/CESTThe issuer is solely responsible ...

GOTHENBURG, SWEDEN / ACCESS Newswire / April 25, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The following resolutions were passed at the Annual General Meeting (the "AGM") of XVIVO ...

The global endocrine testing market is currently valued at USD 2536.7 Million and is projected to grow at a CAGR of 8.5%. As diabetes cases become more prevalent, the global market is expected to ...

The global pessary market is set to experience remarkable expansion, driven by increased awareness of incontinence and pelvic floor disorders. According to a recent report by Future Market Insights, ...

The global medical biomimetics market is on the cusp of unprecedented growth, fueled by cutting-edge research and technological advancements. According to a recent study conducted by leading research ...

The global DNA methylation market is on the verge of a significant surge, with an anticipated market value of USD 1437.5 million in 2023, and projected to skyrocket to USD 5815.49 million by 2033.